Certain Shares of Formycon AG are subject to a Lock-Up Agreement Ending on 2-AUG-2023.
Details:
Following the private placement, Formycon will be subject to a lock-up obligation with market-standard exemptions for a period of six months.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.75 EUR | +3.71% | +3.36% | -20.83% |
25/04 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
18/03 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
1st Jan change | Capi. | |
---|---|---|
-20.83% | 821M | |
+23.37% | 47.02B | |
+49.96% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |